| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0008-8749(03)00148-5 |
| P698 | PubMed publication ID | 12914758 |
| P2093 | author name string | Gabriel Fernandes | |
| Dongxu Sun | |||
| P2860 | cites work | Reduction of platelet activity markers in type II hypercholesterolemic patients by a HMG-CoA-reductase inhibitor | Q73068639 |
| Statins as a newly recognized type of immunomodulator | Q73252634 | ||
| Hydroxymethylglutaryl-coenzyme A reductase inhibition stimulates caspase-1 activity and Th1-cytokine release in peripheral blood mononuclear cells | Q73409194 | ||
| Cytokine modulation of LDL oxidation by activated human monocytes | Q73832892 | ||
| The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells | Q74055104 | ||
| Simvastatin-induced lupus erythematosus | Q77318332 | ||
| Maintenance of NF-kappaB activation in T-lymphocytes and a naive T-cell population in autoimmune-prone (NZB/NZW)F(1) mice by feeding a food-restricted diet enriched with n-3 fatty acids | Q77605810 | ||
| Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells | Q24533532 | ||
| Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
| Atherosclerosis — An Inflammatory Disease | Q26776972 | ||
| Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha | Q28251443 | ||
| Expression of relB is required for the development of thymic medulla and dendritic cells | Q28594949 | ||
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
| The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators | Q29547887 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group | Q29619842 | ||
| Current perspectives on statins | Q33818381 | ||
| Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family | Q34317095 | ||
| Cell cycle-specific effects of lovastatin | Q34532393 | ||
| Simvastatin initiated early after heart transplantation: 8-year prospective experience | Q34648179 | ||
| Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. | Q36367475 | ||
| Lipopolysaccharide-induced NF-kappa B activation in mouse 70Z/3 pre-B lymphocytes is inhibited by mevinolin and 5'-methylthioadenosine: roles of protein isoprenylation and carboxyl methylation reactions | Q36807858 | ||
| Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays | Q37050313 | ||
| Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
| Identifying strategies for immune intervention | Q40907476 | ||
| Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease | Q40913054 | ||
| Stimulation of bone formation in vitro and in rodents by statins | Q40914337 | ||
| Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? | Q40933208 | ||
| Role of the mevalonate pathway of isoprenoid synthesis in IL-8 generation by activated monocytic cells. | Q41462781 | ||
| Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials | Q41535803 | ||
| Dendritic cell survival and maturation are regulated by different signaling pathways. | Q42971737 | ||
| Lipid modulation in insulin-dependent diabetes mellitus: effect on microvascular outcomes | Q43612181 | ||
| Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis | Q43760330 | ||
| Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease | Q43929837 | ||
| Simvastatin reduces expression of cytokines interleukin-6, interleukin-8, and monocyte chemoattractant protein-1 in circulating monocytes from hypercholesterolemic patients. | Q44063984 | ||
| Lovastatin-stimulated superinduction of E-selectin, ICAM-1 and VCAM-1 in TNF-alpha activated human vascular endothelial cells | Q44064882 | ||
| Effect of pravastatin on outcomes after cardiac transplantation. | Q46203599 | ||
| LPS-induced cytokine production and expression of LPS-receptors by peripheral blood mononuclear cells of patients with familial hypercholesterolemia and the effect of HMG-CoA reductase inhibitors | Q47702936 | ||
| Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ. | Q50335866 | ||
| Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia | Q58421218 | ||
| Lovastatin-induced lupus erythematosus | Q67945132 | ||
| Lupuslike syndrome associated with simvastatin | Q68025899 | ||
| Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells | Q71164059 | ||
| Effects of an HMG-CoA reductase inhibitor on cytokine production by human monocytes/macrophages | Q71744118 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P1104 | number of pages | 11 | |
| P304 | page(s) | 52-62 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Cellular Immunology | Q2597167 |
| P1476 | title | Lovastatin inhibits bone marrow-derived dendritic cell maturation and upregulates proinflammatory cytokine production | |
| P478 | volume | 223 |
| Q46972979 | Cytokine secretion via cholesterol-rich lipid raft-associated SNAREs at the phagocytic cup. |
| Q37942858 | Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques |
| Q36300489 | Discovery of BVDU as a promising Drug for autoimmune diseases Therapy by Dendritic-cell-based functional screening |
| Q43194456 | GGTI-2133, an inhibitor of geranylgeranyltransferase, inhibits infiltration of inflammatory cells into airways in mouse experimental asthma |
| Q39643965 | IL-2 Costimulation Enables Statin-Mediated Activation of Human NK Cells, Preferentially through a Mechanism Involving CD56+ Dendritic Cells |
| Q46024300 | Lovastatin inhibits antigen-induced airway eosinophilia without affecting the production of inflammatory mediators in mice. |
| Q37902800 | Metabolism, LXR/LXR ligands, and tumor immune escape. |
| Q33612663 | Modulators affecting the immune dialogue between human immune and colon cancer cells |
| Q40101041 | On the factors modulating the effect of statins on malignant cell proliferation |
| Q57363558 | Pleiotropic Effects of Statins |
| Q57300013 | Prophylactic Treatment With Simvastatin Modulates the Immune Response and Increases Animal Survival Following Lethal Sepsis Infection |
| Q34650855 | Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells |
| Q24603957 | Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism |
| Q37639928 | Statins for community-acquired pneumonia: current state of the science. |
| Q44336248 | Statins inhibit iNOS-mediated microbicidal potential of activated monocyte-derived dendritic cells by an IFN-β-dependent mechanism |
| Q37165311 | Statins' immunomodulatory potential against Th17 cell-mediated autoimmune response |
| Q46758935 | The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease |
| Q33610240 | Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair |
| Q37470209 | Update on statin-mediated anti-inflammatory activities in atherosclerosis |
Search more.